Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biol Pharm Bull ; 42(8): 1275-1281, 2019 Aug 01.
Article in English | MEDLINE | ID: mdl-31155547

ABSTRACT

Polysaccharide is a key bioactive component of Schisandra chinensis and has significant pharmacological activities. The aim of this study was to evaluate the anti-diabetic effect of acidic polysaccharide from Schisandra chinensis (SCAP). Type 2 diabetic (T2D) rats were developed by giving a high-fat diet (HFD) combined with low-dose streptozotocin (STZ), and administered orally with SCAP (25, 50 mg/kg) for 8 weeks. Fasting blood glucose (FBG), fasting insulin (FINS), triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), malondialdehyde (MDA), and superoxide dismutase (SOD) in the rat's serum were measured. Oral glucose tolerance test (OGTT) and pathological changes of pancreas were observed. Furthermore, expressions of c-Jun N-terminal kinase (JNK), B-cell lymphoma 2-associated X protein (BAX), B-cell lymphoma 2 (Bcl-2), and Cleaved Caspase-3 in pancreatic islet were detected. The results showed that SCAP decreased FBG, TG, TC, LDL-C and MDA levels, increased insulin, HDL-C levels and SOD activity, improved the pathological changes in pancreatic islet. Furthermore, SCAP inhibited the up-regulation of phosphorylated JNK, BAX and Cleaved Caspase-3 proteins, and increased Bcl-2 protein expression. These data indicate that SCAP has a therapeutic effect in T2D rats, and the mechanism may be related to its protection against ß-cells apoptosis by regulating apoptosis-related proteins expression to alleviate the injury caused by the oxidative stress.


Subject(s)
Diabetes Mellitus, Type 2/drug therapy , Polysaccharides/pharmacology , Schisandra/chemistry , Animals , Blood Glucose/drug effects , Caspase 3/metabolism , Diabetes Mellitus, Type 2/chemically induced , Diet, High-Fat , Drugs, Chinese Herbal/pharmacology , Fasting , Glucose Tolerance Test , Insulin/blood , Lipids/blood , MAP Kinase Kinase 4/metabolism , Male , Malondialdehyde/metabolism , Pancreas/metabolism , Pancreas/pathology , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Wistar , Streptozocin , Superoxide Dismutase/metabolism , bcl-2-Associated X Protein/metabolism
2.
Mol Plant Pathol ; 15(4): 333-41, 2014 May.
Article in English | MEDLINE | ID: mdl-24286630

ABSTRACT

Bacterial blight (BB), caused by Xanthomonas oryzae pv. oryzae (Xoo), is not only a disease devastating rice production worldwide, but also an ideal model system for the study of the interaction between plants and their bacterial pathogens. The rice near-isogenic line (NIL) CBB23, derived from a cross between a wild rice Oryza rufipogon accession (RBB16) and a susceptible indica rice variety (Jingang 30), is highly resistant to all field Xoo strains tested so far. Although the BB resistance of CBB23 has been widely used in rice breeding programmes, the mechanism of its extremely broad-spectrum resistance remains unknown. Here, we report the molecular cloning of an avirulence gene, designated as avrXa23, from Xoo strain PXO99(A) . We validate that AvrXa23, a novel transcription activator-like effector, specifically triggers the broad-spectrum BB resistance in CBB23. The prevalence of avrXa23 in all 38 Xoo strains surveyed may explain the broad-spectrum feature of BB resistance in CBB23. The results will significantly facilitate the molecular cloning of the corresponding resistance (R) gene in the host, and provide new insights into our understanding of the molecular mechanism for broad-spectrum disease resistance in plants.


Subject(s)
Bacterial Proteins/metabolism , Oryza/metabolism , Oryza/parasitology , Plant Diseases/microbiology , Xanthomonas/pathogenicity , Gene Expression Regulation, Plant , Molecular Sequence Data
SELECTION OF CITATIONS
SEARCH DETAIL
...